Objetivo
Development of new medicines such as chemotherapeutic drugs requires a detailed understanding of their biological mechanism of action. What are the desired and undesired interactions with biological molecules? It is our goal to found a start-up company that will provide a solution to this challenge. Using novel and ground-breaking approaches we can identify target structures and interaction partners of small bioactive molecules at an unmatched and unprecedented resolution. ERC PoC funding will be essential to support our activities to identify optimal strategies and initial customers for our service.
Ámbito científico
Programa(s)
Régimen de financiación
ERC-POC - Proof of Concept GrantInstitución de acogida
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Aportación neta de la UEn
€ 149 563,00
Dirección
HOFGARTENSTRASSE 8
80539 Munchen
Alemania
80539 Munchen
Alemania
Región
Bayern
Oberbayern
München, Kreisfreie Stadt
Tipo de actividad
Research Organisations
Enlaces
Coste total
€ 149 563,00